🛡️ Public data only — no PHI permitted on this instance.
SC
SeekingChartis
Investment Committee Memorandum | FL | 350 beds | Grade C | EBITDA uplift $26.5M
Investment Committee Memorandum

OAK HILL HOSPITAL

CCN 100264 | HERNANDO, FL | 350 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

OAK HILL HOSPITAL is a 350-bed suburban community hospital in HERNANDO, FL with $359.9M in net patient revenue and a 28.3% operating margin. The hospital serves a payer mix of 26.6% Medicare, 2.1% Medicaid, and 71.2% commercial.

Thesis: Platform Growth. Our ML models identify $26.5M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 28.3% to 35.6% (+736bps).

Net Revenue HCRIS$359.9M
Current EBITDA COMPUTED$101.7M
Operating Margin COMPUTED28.3%
Occupancy HCRIS80.4%
Revenue / Bed COMPUTED$1.0M
Net-to-Gross HCRIS8.0%
Distress Probability ML39.3%

2. Market Context & Competitive Position

261
FL Hospitals
3.2%
State Median Margin
96
Comparable Hospitals

FL has 261 Medicare-certified hospitals with a median operating margin of 3.2%. The target's margin of 28.3% places it above the state median. Among 96 size-comparable peers (175-700 beds), the median margin is 5.0%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (175-700), prioritizing same-state peers. 96 hospitals in the comp set.

HospitalStateBedsRevenueMargin
OAK HILL HOSPITAL (Target)FL350$359.9M28.3%
UNIVERSITY OF MIAMI HOSP & CLIFL532$2.36B0.9%
MOFFITT CANCER CENTERFL218$1.91B16.0%
MAYO CLINIC FLORIDAFL304$1.09B21.6%
ASCENSION SACRED HEART PENSACOFL559$1.04B-10.0%
MOUNT SINAI MEDICAL CENTER OF FL481$904.2M12.2%
TALLAHASSEE MEMORIAL HOSPITALFL483$871.6M-4.8%
SHANDS JACKSONVILLE MEDICAL CEFL481$861.4M-7.1%
MORTON PLANT HOSPITALFL561$773.1M7.7%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $26.5M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$7.6M+210bp18mo
Cost to Collect4.5%2.5%$7.2M+200bp12mo
Denial Rate Reduction12.0%6.5%$7.1M+198bp12mo
A/R Days Reduction5200.0%3800.0%$4.4M+122bp9mo
Clean Claim Rate88.0%96.0%$230K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$7.6M
Cost to Collect
$7.2M
Denial Rate Reduction
$7.1M
A/R Days Reduction
$4.4M
Clean Claim Rate
$230K
Total EBITDA Uplift$26.5M
Current EBITDA$101.7M
+ RCM Uplift+$26.5M
Pro Forma EBITDA$128.2M
Current Margin28.3%
Pro Forma Margin35.6%
WC Released (1x)$13.8M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$156.5M$936.0M5.98x43.0%
Base (11x exit)10.0x11.0x$156.5M$1.08B6.90x47.2%
Bull Case9.0x11.0x$140.9M$1.22B8.65x54.0%
Bull (12x exit)9.0x12.0x$140.9M$1.37B9.73x57.6%
Bear Case11.0x10.0x$172.2M$752.7M4.37x34.3%
Bear (11x exit)11.0x11.0x$172.2M$883.9M5.13x38.7%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 96 hospitals with 175-700 beds
  • Same-state prioritization (n=97)
  • Comp margins: P25=-4.7% / P50=5.0% / P75=18.5%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.

Full EBITDA BridgeML AnalysisHospital ProfileStatistical ProfileDeal Screener